ICPMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
    1. Databases

    1. Industries

    1. Instrumentation

    1. Manufacturer

    1. Author

    1. Content Type

    1. Publication Date

    Applications from the field of Pharma & Biopharma focused on UV–VIS spectrophotometry | LabRulez ICPMS

    Agilent Cary 60 UV-Vis - PERFORMANCE, RELIABILITY AND COMPLIANCE

    Others
    | 2016 | Agilent Technologies
    UV–VIS spectrophotometry
    Instrumentation
    UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent Cary WinUV Pharma

    Technical notes
    | 2016 | Agilent Technologies
    Software, UV–VIS spectrophotometry
    Instrumentation
    Software, UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Spectroscopy Solutions for Pharmaceuticals

    Technical notes
    | 2016 | Agilent Technologies
    UV–VIS spectrophotometry
    Instrumentation
    UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Pharmaceutical Analysis Using UV-Vis: Compliance with USP Chapter <857>, and European Pharmacopoeia (Ph. Eur. Chapter 2.2.25)

    Applications
    | 2020 | Agilent Technologies
    UV–VIS spectrophotometry
    Instrumentation
    UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent Cary UV Workstation Software for Cary 3500

    Technical notes
    | 2021 | Agilent Technologies
    Software, UV–VIS spectrophotometry
    Instrumentation
    Software, UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Pharmaceutical Analysis using UV-Vis: Compliance with Supplement I to the Japanese Pharmacopoeia 18th Ed., Section 2.24

    Technical notes
    | 2021 | Agilent Technologies
    Software, UV–VIS spectrophotometry
    Instrumentation
    Software, UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Better Data Integrity With the Cary 3500 Simultaneous Multicell UV-Vis and a System Approach to ALCOA+

    Others
    | 2019 | Agilent Technologies
    UV–VIS spectrophotometry
    Instrumentation
    UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    USP General Chapter <857> and Ph. Eur. Chapter 2.2.25 10th Edition

    Others
    | 2019 | Agilent Technologies
    UV–VIS spectrophotometry
    Instrumentation
    UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Data Integrity Options for GMP Facilities For the Agilent Cary 3500 UV-Vis Spectrophotometer

    Others
    | 2022 | Agilent Technologies
    Software, UV–VIS spectrophotometry
    Instrumentation
    Software, UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Characterization of Protein Thermal Stability Using UV-Vis Spectroscopy

    Applications
    | 2022 | Agilent Technologies
    UV–VIS spectrophotometry
    Instrumentation
    UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma
     

    Related content


    Wiley released AntiBase Library 2024 – the Latest Version of Wiley Identifier of Natural Products

    Su, 28.4.2024
    LabRulez

    Scientists continue to push the boundaries of imaging techniques and reveal the mysterious world of molecules

    Th, 25.4.2024
    Ústav organické chemie a biochemie AV ČR

    Preventing early-onset colorectal cancers aim of $25 million award

    Tu, 23.4.2024
    Washington University in St. Louis
    Other projects
    Follow us
    More information
    WebinarsAbout usContact usTerms of use
    LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike